SAB Biotherapeutics, Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: 305-845-2813
EIN: 853899721
State Location: FL
State of Inc.: DE
- Nasdaq:SABS
- Nasdaq:SABSW
Form: SCHEDULE 13G
Filing Date: 03 Oct 2025Report Date:
Accepted: 03 Oct 2025 06:30 p.m.
Accession Number: 0001213900-25-096128
File Number: 005-92283
Film Number: 251374388
Documents
Primary Document
Accepted: 03 Oct 2025 06:30 p.m.
0001213900-25-096128-index-headers.html
Last Modified: 03 Oct 2025 02:30 p.m.
0001213900-25-096128-index.html
Last Modified: 03 Oct 2025 02:30 p.m.
0001213900-25-096128.txt
Last Modified: 03 Oct 2025 02:30 p.m.
ea026016801ex99-1_sab.htm
Last Modified: 03 Oct 2025 02:30 p.m.
primary_doc.xml
Last Modified: 03 Oct 2025 02:30 p.m.